Enlivex Slides to Record Low as Its $1.2bn RAIN Treasury Draws Fraud Scrutiny

Shares in Enlivex Therapeutics, a Nasdaq-listed biotech that reinvented itself last year as a digital asset treasury vehicle, fell to an all-time low of $0.42 on Tuesday, according to Protos, even as the crypto token underpinning its treasury strategy has climbed in value. The divergence has intensified regulatory and analyst attention on how the company valued and disclosed its holdings.

Enlivex, which has traded publicly for twelve years, abandoned its clinical therapeutics business in November 2025 to pursue what it described as the “world’s first prediction markets digital asset treasury strategy”. It raised more than $200 million through a private placement priced at $1 a share, funded in dollars and USDT, and used the proceeds to accumulate RAIN, the governance token of an Arbitrum-based prediction markets protocol it marketed as “the Uniswap of prediction markets”.

A widening gap between treasury and market value

The company now holds roughly 78.8 billion RAIN tokens, equivalent to 12% of the token’s circulating supply and worth some $1.2 billion at current mark-to-market prices, per Protos. Yet Enlivex’s own market capitalisation stands at just $118 million, a gap that analysts say points to encumbrances on the tokens or other structural problems, with some of the RAIN holdings reportedly pledged as collateral.

RAIN is described as thinly traded, meaning a large or sudden sale by Enlivex could realise far less than its stated valuation. The stock has fallen 94% over the past five years, including a 30% decline so far in 2026, leaving even privileged investors who bought into the November placement at $1 nursing losses of roughly half their stake.

ZachXBT traces token to Hogeg-linked wallets

On-chain investigator ZachXBT first flagged RAIN in May, writing that the token’s structure meant investors “only provide exit liquidity for insiders” and that the “team is tied to a sketchy DAT Enlivex & launchpad Gems[.]vip”. In a follow-up, he traced RAIN’s funding to blockchain addresses previously used to move money for two failed projects, TOMI and Data Ownership Protocol, both connected to Israeli entrepreneur Moshe Hogeg.

Hogeg, who co-founded TOMI, is facing a law enforcement investigation reportedly valued at $290 million and has denied fraud allegations through a spokesperson. Enlivex’s board includes a former Italian prime minister, appointed as part of the company’s rebranding around the RAIN treasury.

A recurring pattern for retail investors

The Enlivex episode adds to a series of episodes in which retail capital has flowed toward tokens linked to Hogeg’s ventures, only for the associated public vehicles to underperform sharply. For a listed company, the combination of an opaque token valuation, apparent collateral encumbrances, and unresolved links to an entrepreneur under investigation raises the kind of disclosure and governance questions that securities regulators typically scrutinise most closely in digital asset treasury structures.

Read more: Enlivex’s Record Low Renews Scrutiny of Small-Cap Crypto Treasury Pivots